You are here

  • Home
  • Archive
  • Volume 4, Issue 5
  • Delayed intraparenchymal hemorrhage following pipeline embolization device treatment for a giant recanalized ophthalmic aneurysm

Article Text

Article menu
Download PDFPDF
Electronic pages
Case reports
Delayed intraparenchymal hemorrhage following pipeline embolization device treatment for a giant recanalized ophthalmic aneurysm
  1. Gregory J Velat1,
  2. Kyle M Fargen1,
  3. Matthew F Lawson1,
  4. Brian L Hoh1,
  5. David Fiorella2,
  6. J Mocco1
  1. 1Department of Neurological Surgery, University of Florida, Gainesville, Florida, USA
  2. 2Department of Neurosurgery, State University of New York at Stony Brook, Stony Brook, New York, USA
  1. Correspondence to Dr J Mocco, Neurological Surgery, University of Florida, Gainesville, FL 32610, USA; jmocco{at}neurosurgery.ufl.edu

Abstract

The pipeline embolization device has demonstrated clinical success in the management of complex intracranial aneurysms arising along the anterior intracranial circulation with a relatively low complication profile. A case report is presented which describes a novel complication of delayed intraparenchymal hemorrhage following deployment of a pipeline embolization device for the treatment of a previously ruptured partially thrombosed ophthalmic segment aneurysm.

  • Angiography
  • aneurysm
  • arteriovenous malformation
  • embolic
  • artery
  • spinal cord
  • subarachnoid
  • thrombectomy
  • catheter
  • navigation
  • complication
  • neck
  • balloon
  • thrombolysis
  • stroke
  • stenosis
  • malformation
  • coil
  • brain
  • atherosclerosis
  • angioplasty

https://doi.org/10.1136/neurintsurg-2011-010129

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Competing interests None.

    • Ethics approval Ethics approval was not obtained as our institution does not require IRB approval for a case report involving one patient.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    • Data sharing statement The data have not been disseminated in any form to other institutions or journals.